Coherus Oncology, Inc. (CHRS)
1.61
+0.04
(+2.55%)
USD |
NASDAQ |
May 22, 16:00
1.615
0.00 (0.00%)
After-Hours: 20:00
Coherus Oncology EPS Diluted (Quarterly) : -0.2782 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| Myriad Genetics, Inc. | -0.3639 |
| Vaxart, Inc. | 0.0214 |
| BioRestorative Therapies, Inc. | -0.1215 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.94M |
| Revenue (Quarterly) | 12.31M |
| Total Expenses (Quarterly) | 49.24M |
| Enterprise Value | 135.67M |
| Gross Profit Margin (Quarterly) | 61.86% |
| Profit Margin (Quarterly) | -300.0% |
| Earnings Yield | -77.40% |
| Normalized Earnings Yield | -76.61 |